TGM2 and breast carcinoma: For example, the release of CLIC3 from both tumor and stromal cells into the tumor microenvironment stimulates the invasion of endothelial cells and invasive pseudopods from breast cancer cells through its oxidoreductase activity on transglutaminase-2 that modifies the stiffness of the extracellular matrix [58].